Search results
Results from the WOW.Com Content Network
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California, wholly owned by the Swiss multinational pharmaceutical company, the Roche Group. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. [6]
At the time of his retirement from the CDC, he was the centers' AIDS Advisor to the State of California and Special Consultant to Mayor Art Agnos in San Francisco. [9] In the latter capacity he served as the Chair of the Mayor's HIV Task Force. In 1993, Francis joined Genentech, Inc., of South San Francisco to try to develop a vaccine for HIV.
Robert "Bob" Swanson (1947–1999) was an American venture capitalist who co-founded Genentech in 1976 with Herbert Boyer. Genentech is one of the leading biotechnology companies in the world. He was CEO of Genentech from 1976 to 1990, and chairman from 1990 to 1996.
Pages in category "Drugs developed by Genentech" The following 102 pages are in this category, out of 102 total. This list may not reflect recent changes. A.
Together with Steve McKnight and Robert Tjian, he founded Tularik in 1991, and was their president and CEO until Tularik was acquired by Amgen for $1.3 billion in 2004. [3] Goeddel earned his bachelor's degree in chemistry from the University of California, San Diego, and his PhD in biochemistry from the University of Colorado, Boulder.
[7] Boyer cofounded Genentech in 1976 based on their work together, but Cohen was a consultant for Cetus Corporation and declined to join. [8] In 2022, Cohen was found guilty of having committed fraud in misleading investors into a biotechnology company he founded in 2016, and paid $29 million in damages. [9]
University of California, San Francisco (UCSF), Calico (company), Genentech, Hoffmann-La Roche Hal V. Barron (born 1962) is an American clinician-scientist and drug developer who served as president of research and development at GlaxoSmithKline from March 2018 [ 1 ] until 2022, when he resigned in order to join the cellular reprogramming ...
This page was last edited on 27 January 2024, at 21:48 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.